A systematic review published in Vaccines found that Parsonage–Turner syndrome (PTS) is linked to the COVID-19 vaccine.
PTS affects the peripheral nervous system and involves severe pain and muscular atrophy.
To study the occurrence of PTS after inoculation, researchers examined LitCOVID and the World Health Organization’s COVID-19 databases, finding 59 instances of the disorder.
Of those occurrences, 36 individuals received an mRNA vaccine and 18 individuals received a non-mRNA vaccine.
“Current evidence suggests PTS may occur after all COVID-19 vaccine types, with some subgroup differences,” the researchers concluded. “Also, PTS might recur with subsequent similar or unrelated vaccines.”
Research published in the Nature Cardiovascular Research journal and acknowledged by the U.S. National Institutes of Health (NIH) similarly highlighted a connection between COVID-19 vaccines and an increase in the incidence of Postural Orthostatic Tachycardia Syndrome (POTS), a disorder of the autonomic nervous system.
“POTS can follow COVID-19 as part of the post-acute sequelae of SARS-CoV-2 infection, but it can also develop after COVID-19 vaccination,” the researchers confirmed in their paper. “A new study shows that the rate of new-onset POTS diagnoses is slightly increased after COVID-19 vaccination.”
The study highlights a key finding: “They found that the odds of POTS and associated diagnoses were higher in the 90 days after vaccine exposure than the 90 days before exposure, with a relative risk increase of 33%.”
Another study published in the digital journal Cureus acknowledged that the risks presented by the COVID-19 mRNA vaccines “outweigh the rewards.”
It suggested that “for every life saved, there were nearly 14 times more deaths caused by the modified mRNA injections.”
According to the study’s authors, the claim that the mRNA vaccines were “safe and effective” was “dubious at best,” explaining that it took an estimated 52,000 vaccinations to prevent one death.
